SAP AG has partnered with Inventages, a global healthcare venture capital fund backed by Nestlé, to integrate a mechanism based approach to disease management with information technology frameworks to develop the next generation personalized medicine companies.
Sigg added that both Inventages and Nestlé have experience in healthcare technology development, designing and running clinical trials and navigating complicated regulatory and reimbursement environments.
According to the release, personalized medicine uses genetic and non-genetic information to individualize the prevention, diagnosis, and treatment of disease.
Since the approach will require the integration of multiple data sources, such as a patient’s genomic information, medical history, environmental and lifestyle factors and the structuring and analysis of large data volumes, Inventages needed to partner with an established IT company.
“Inventages has been looking at personalized medicine for several years and consequently we recognize that the future of disease management needs to be holistic; all of the factors that influence a patient’s health need to be considered,” said Dr. Gunnar Weikert, chairman and managing partner of Inventages.
“Inventages and SAP are aligned in their vision to advance personalized medicine through the use of IT. This collaboration plans to provide our companies with access to SAP’s capabilities and resources in mobile, cloud and big data processing,” he added.
According to SAP, the partnership is meant to provide emerging healthcare companies with capital and extensive resources and expertise.
The collaboration also plans to leverage Inventages’ experience in the development of clinically validated products.